Delivery Order SPE2DB22D2007-SPE2DB23FJ2DM
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of OLOPATADINE HCL 0.1% eye drops, a pharmaceutical product, with a ceiling value of $2,987.69 and a completion date of January 14, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, that serves as a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Olopatadine Hydrochloride 0.1% eye drops. The $2,112.82 firm-fixed-price contract has a performance period through May 2025 and is not set aside. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Olopatadine HCl 0.1% eye drops, a prescription medication, with a ceiling value of $1,741.97 and a performance period through April 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical,...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Olopatadine HCl 0.1% eye drops in 5 ml vials, with a total ceiling value of $1,696.92 and a completion date of January 27, 2025. The contract is a firm fixed-price Delivery Order and does not have a set-aside designation, indicating open competition....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Olopatadine HCl 0.1% eye drops. The contract has a ceiling value of $1,034.90 and a completion date of June 24, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,534.46, is for the supply of Olopatadine HCl 0.1% eye drops in 5 mL containers. The contract has a firm fixed-price pricing type and an ultimate completion date of September 25, 2024. This contract is not set aside for a specific socioeconomic business category. Amerisourcebergen, as a prominent supplier of pharmaceutical...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,308.39, is for the delivery of OLOPATADINE HCL 0.1% eye drops in 5ml quantities. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Olopatadine HCL 0.1% eye drops in 5ml units, with a ceiling value of $2,398.95. This is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and was awarded on September 5, 2025. The contract represents a non-set-aside award under open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's largest...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of OLOPATADINE HCL 0.1% EYE DROPS 5ML, with a ceiling value of $1,355.53 and a performance period through April 15, 2024. This delivery order contract is issued under a larger indefinite delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Olopatadine HCl 0.1% eye drops. The contract has a ceiling value of $2,252.93 and is a firm fixed price delivery order with a period of performance through March 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB23FJ2DMDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Olopatadine HCL 0.1% eye drops, a pharmaceutical product, with a ceiling value of $1,167.76 and a period of performance ending on May 5, 2023. The contract is a firm fixed-price delivery order and was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 5/4/23 |